Kahlert Institute for Addiction Medicine

What Kahlert Institute for Addiction Medicine does

The Kahlert Institute for Addiction Medicine is a non-profit academic research institute founded in 2023 and housed within the University of Maryland School of Medicine in Baltimore, Maryland. It operates as an integral component of UMSOM, with faculty scientists, physician educators, and clinicians serving as the institute's core human capital. The institute's mission is to combat substance misuse by integrating advanced neuroscience research, evidence-based clinical care (including harm reduction and overdose response), medical education, and prevention across Maryland.

Its core programmatic offerings include the Overdose Response Program (providing naloxone distribution and harm reduction services), participation in the NIDA Clinical Trials Network (providing access to federally-coordinated addiction medicine clinical trials and patient recruitment), Study Recruitment, an Annual Research Symposium, a recurring Seminar Series, and newsletter and social media communications. The underlying technology base is conventional academic medicine: evidence-based harm reduction protocols, clinical care pathways delivered through the University of Maryland Medical Center, and neuroscience research into brain mechanisms of addiction. No proprietary technology platform or AI/ML components are disclosed.

The institute's revenue model is non-commercial: funding flows from research grants (including NIDA Clinical Trials Network participation and broader UMSOM academic research funding) and philanthropic support, principally from The Kahlert Foundation. It serves three primary constituencies: Maryland patients and communities affected by substance use disorder (clinical care), medical students and physician residents (training and education), and the broader addiction research community (clinical trials and academic dissemination). Pricing is not applicable as services are delivered through the academic medical center and university system rather than a commercial channel.

Name

Kahlert Institute for Addiction Medicine

Legal name

Kahlert Institute for Addiction Medicine

Website

https://addiction.umaryland.edu

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

The Kahlert Institute for Addiction Medicine is a 2023-founded non-profit research institute within the University of Maryland School of Medicine that integrates addiction neuroscience research, evidence-based clinical care including harm reduction, and medical education, serving Maryland patients, trainees, and the research community.

Ownership category

akta.pro rank

Product category

Addiction Medicine Research and Clinical Care

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAFABAD

Outpatient Substance Use Disorder (SUD) Treatment Programs

Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

SECONDARYBPAGACAE

Substance Use Disorder Prevention & Recovery Services

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

Keywords

• Addiction medicine research
• Substance use treatment
• Harm reduction services
• Clinical trials network
• Medical education training

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Others

Revenue model

1. Research Funding: Funded through research grants including NIDA Clinical Trials Network participation and academic research funding from the University of Maryland School of Medicine.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

The Kahlert Institute for Addiction Medicine combats substance misuse through advanced research and clinical care, providing addiction research, prevention, treatment, and education. Its core services include an overdose response program with naloxone distribution, participation in the NIDA Clinical Trials Network, study recruitment, and educational programs such as an annual research symposium and seminar series, all delivered through the University of Maryland School of Medicine and Medical System.

Product overview

The Kahlert Institute for Addiction Medicine operates as a research and clinical care institute under the University of Maryland School of Medicine, offering a portfolio of programs focused on addiction research, prevention, treatment, and education. The core offerings include the Overdose Response Program providing naloxone distribution and harm reduction services, participation in the NIDA Clinical Trials Network for clinical research, and Study Recruitment services. Educational initiatives include the Annual Research Symposium and Seminar Series. The institute's programs work together to advance addiction medicine across Maryland through collaborative research, clinical care, and training of medical professionals.

Differentiator

Problem solved

Functional benefit

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• University of Maryland School of MedicinecoreStrategic or Co-development PartnerThe institute is an integral part of the University of Maryland School of Medicine. Faculty scientists including neuroscientists and physician educators serve as part of the institute. Located within UMSOM facilities at 655 W. Baltimore Street.
• NIDA Clinical Trials NetworkcoreStrategic or Co-development PartnerThe institute participates in the National Institute on Drug Abuse (NIDA) Clinical Trials Network, enabling access to national clinical trials in addiction medicine and collaborative research opportunities.
• University of Maryland Medical CentercoreStrategic or Co-development PartnerClinical care partner providing the hospital-based setting for addiction medicine services and treatment programs delivered by institute clinicians.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Treatment Research Institute (dba Center for Integrated Behavioral Health): Research nonprofit historically focused on translating addiction science into clinical practice. Comparable as a research-driven addiction-focused nonprofit operating alongside academic medical partners.
• Caron Treatment Centers: Nonprofit addiction treatment organization providing inpatient, outpatient, and educational programming for substance use disorders. Comparable to Kahlert in mission alignment across treatment, research, and prevention.
• Center for Addiction Medicine, Massachusetts General Hospital: Academic medical-center-based program delivering addiction medicine clinical care, research, and training within Mass General Brigham. Comparable as an integrated academic addiction medicine center with NIDA-affiliated research.
• Johns Hopkins Medicine - Behavioral Pharmacology Research Unit: Baltimore-based academic addiction research unit within Johns Hopkins. Comparable to Kahlert given shared geography, academic-affiliation structure, and focus on substance use clinical trials.
• Columbia University Division on Substance Use Disorders: Academic division at Columbia conducting SUD research, clinical care, and physician training. Comparable to Kahlert in integrating neuroscience research with clinical addiction services within an academic medical school.
• Friends Research Institute: Nonprofit research organization specializing in clinical trials and behavioral research on substance use disorders, including NIDA CTN participation. Closely comparable to Kahlert's research-focused activities within the NIDA CTN.
• Hazelden Betty Ford Foundation: Major nonprofit addiction treatment and education provider offering outpatient, residential, and continuing care programs across multiple states. Comparable to Kahlert in integrating clinical addiction care, research, and professional training.

Broad incumbents

• McLean Hospital (Harvard Medical School): Major psychiatric and substance use treatment hospital affiliated with Harvard, conducting clinical care, research, and training. Comparable as a larger academic addiction/behavioral health entity with overlapping research and clinician-training functions.
• Recovery Centers of America: Multi-site addiction treatment provider with inpatient and outpatient services across the Mid-Atlantic and Northeast, including Maryland-adjacent facilities. Comparable as a regional SUD treatment operator with overlapping Maryland reach.

Others

• National Center on Addiction and Substance Abuse (CASAColumbia): National nonprofit research and policy organization focused on addiction as a public health issue. Comparable as a mission-aligned nonprofit working at the intersection of addiction research, prevention, and policy rather than direct clinical care.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/Kahlert_UMSOM
• LinkedInlinkedin.com/company/kahlert-institute-for-addiction-medicine

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kahlert Institute for Addiction Medicine